Annual Covalent Drug Discovery & Development Summit

The Annual Covalent Drug Discovery & Development Summit is a premier industry forum dedicated to advancing covalent therapeutics from discovery through to Investigational New Drug (IND) applications and early clinical development. It addresses the evolving landscape of covalent drug discovery, where successful clinical translation has become the focal point, moving beyond concerns of off-target toxicity to unlock previously undruggable targets. With the advent of next-generation warheads, chemoproteomics, and AI-driven design, the summit highlights critical translational strategies necessary for transforming covalent candidates into safe and effective clinical therapies.This summit offers a unique platform for networking and collaboration, featuring over seven hours of dedicated networking time where participants can engage with like-minded professionals and experts in the field. Attendees will benefit from data-driven case studies, candid insights not typically found in publications, and discussions that focus on overcoming challenges related to selectivity, safety, and pharmacokinetics/pharmacodynamics (PK/PD). Key speakers and industry leaders will share their experiences and strategies in bridging the gap from discovery to clinical success, fostering a rich environment for cross-disciplinary exchange and innovation. The event aims to create a comprehensive understanding of today’s covalent drug discovery landscape, encouraging collaborations that will ultimately drive the field forward and enhance patient outcomes globally.